Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Fennec Pharmaceuticals Inc.
  6. News
  7. Summary
    FENC   CA31447P1009

FENNEC PHARMACEUTICALS INC.

(FENC)
  Report
Delayed Nasdaq  -  04:00:00 2023-03-24 pm EDT
7.590 USD   +2.85%
06:17aNorth American Morning Briefing: Stock Futures -2-
DJ
03/17North American Morning Briefing: Focus on Bank -2-
DJ
03/03North American Morning Briefing: More Fed -3-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about FENNEC PHARMACEUTICALS INC.
02/01Fennec pharmaceuticals announces pedmark(sodium thiosulfate injection) receives orphan ..
AQ
01/31Fennec Pharmaceuticals' Pedmark Receives Orphan Drug Exclusivity from U.S. FDA
MT
01/31Fennec Pharmaceuticals Obtains Orphan Drug Exclusivity From FDA for Cisplatin-Linked He..
MT
01/31Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orpha..
GL
01/31Fennec Pharmaceuticals Inc. Announces Pedmark® (Sodium Thiosulfate Injection) Receives ..
CI
01/26Fennec pharmaceuticals announces updated nccn clinical practice guidelines recommend pe..
AQ
01/25Wedbush on Fennec Pharmaceuticals' NCNN Update
MT
01/25Wedbush Lowers Fennec Pharmaceuticals' Price Target to $17 From $19, Maintains Outperfo..
MT
01/25Fennec Says Updated Clinical Practice Guidelines Recommend Pedmark to Reduce Risk of He..
MT
01/25Fennec Pharmaceuticals Brief: Announcing Updated NCCN Clini..
MT
01/25Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PE..
GL
01/25Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PE..
AQ
01/25Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PE..
CI
2022Insider Sell: Fennec Pharmaceuticals
MT
2022Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight From Neutral, Adjusts P..
MT
More most relevant news
All news about FENNEC PHARMACEUTICALS INC.
06:17aNorth American Morning Briefing: Stock Futures -2-
DJ
03/17North American Morning Briefing: Focus on Bank -2-
DJ
03/03North American Morning Briefing: More Fed -3-
DJ
02/24North American Morning Briefing: Stock Futures -3-
DJ
02/01Fennec pharmaceuticals announces pedmark(sodium thiosulfate injection) receives orphan ..
AQ
01/31Fennec Pharmaceuticals Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/31Fennec Pharmaceuticals' Pedmark Receives Orphan Drug Exclusivity from U.S. FDA
MT
01/31Fennec Pharmaceuticals Obtains Orphan Drug Exclusivity From FDA for Cisplatin-Linked He..
MT
01/31Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orpha..
GL
01/31Fennec Pharmaceuticals Inc. Announces Pedmark® (Sodium Thiosulfate Injection) Receives ..
CI
More news
News in other languages on FENNEC PHARMACEUTICALS INC.
01/31Fennec Pharmaceuticals obtient de la FDA l'exclusivité des médicaments orphelins pour l..
01/31Fennec Pharmaceuticals Inc. annonce que Pedmark® (Thiosulfate de sodium injectable) reç..
01/25Wedbush sur la mise à jour de NCNN de Fennec Pharmaceuticals
01/25Fennec Pharmaceuticals annonce que la mise à jour des directives de pratique clinique d..
2022Vente d'initiés : Fennec Pharmaceuticals
2022Fennec Pharmaceuticals affiche une perte nette de 8,1 millions de dollars US au troisiè..
2022Fennec Pharmaceuticals Inc. annonce ses résultats pour le troisième trimestre terminé l..
2022Fennec Pharmaceuticals Inc. annonce la disponibilité commerciale de PEDMARK(R) (thiosul..
2022Un client de Berkshire Sterile, Fennec Pharmaceuticals Inc. reçoit l'approbation de la ..
2022Fennec Pharmaceuticals annonce l'approbation de Pedmark par la FDA
More news
Analyst Recommendations on FENNEC PHARMACEUTICALS INC.
01/25Wedbush Lowers Fennec Pharmaceuticals' Price Target to $17 From $19, Maintains Outperfo..
MT
2022Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight From Neutral, Adjusts P..
MT
2022HC Wainwright Adjusts Fennec Pharmaceuticals' Price Target to $18 From $14, Keeps Buy R..
MT
2022Maxim Adjusts Fennec Pharmaceuticals' Price Target to $15 from $10, Maintains Buy
MT
2022Wedbush Adjusts Fennec Pharmaceuticals Price Target to $19 From $11, Maintains Outperfo..
MT
More recommendations
Press releases
02/01Fennec pharmaceuticals announces pedmark(sodium thiosulfate injection) receives orphan ..
AQ
01/31Fennec Pharmaceuticals Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/31Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orpha..
GL
01/26Fennec pharmaceuticals announces updated nccn clinical practice guidelines recommend pe..
AQ
01/25Fennec Pharmaceuticals Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More press releases
Upcoming event on FENNEC PHARMACEUTICALS INC.
03/29/23FY 2022 Earnings Release (Projected)
Upcoming sector events
03/27/23BIONTECH SE : FY 2022 Earnings Release
05/02/23WUXI APPTEC CO., LTD. : Q1 2023 Earnings Release (Projected)
05/03/23VERTEX PHARMACEUTICALS INCORPORATED : Q1 2023 Earnings Release (Projected)
05/04/23REGENERON PHARMACEUTICALS, INC. : Q1 2023 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Stock markets for all
100% Free Registration
fermer